April 12 Harborside Atrium

Venture Conference

Venture Conference

About

The Tech Council’s 21st annual Venture Conference showcases the region’s most promising companies and leading professional service firms. In past years, the Conference has attracted over 500 entrepreneurs, developers, investors, venture capitalists, investment bankers, lenders and other financing groups from the northeast corridor. In addition, students and professional advisors participate in the Conference.

REGISTRATION CLOSED – WALK-INS WELCOME. 
If you have a discount code, it will be honored at registration desk.

Click here PARKING DIRECTIONS

Days
Hours
Minutes
Seconds

Schedule

 
 2:00 PM

Registration/Exhibits Open

 3:00 PM

Opening Remarks

James Barrood, President & CEO, NJ Tech Council
Michael DeMarco, CEO, Mack-Cali

 3:05 PM

Keynote

Ben Lehnert, Microsoft
 3:40 PM

Pitches - Round 1

Barkly
Nutrivide
Acreto.Cloud
Sensors and Stitches
KidGooRoo
Injii
Tradiuus
OpenSponsorship
Seamless.AI
Bright Cloud International Corp.
D3 Unified Communications
Treadstone Technologies, Inc.
Bill Karma
Morris Technology Partners
Reflik
VitalStart Health
Gigzolo
Ricovr Healthcare
EVT-X Innovation
Bran Management
Thinkster Math

 4:20 PM

Networking

 4:40 PM

Pitches - Round 2

Boxcar
SuitableYou LLC
Raflbot
SPENT
Bixby
HotSpotGOT LLC
Eventdex
Face2Face Health
FokisOn
URSA
Biem
Socium Therapeutics
Full Cycle Channel
Carii
Tendo Technologies, Inc.
Saturn Care
Agilis Chemicals LLC
Icebrkr
Enersave
URB Sciences
Small Factory Innovations

 5:20 PM

Funding Panel

Deborah Zajac, Touchdown Ventures
Kelly Ford, Edison Partners
Gina Tedesco, Jumpstart Angels
Kathleen Coviello, NJEDA
Moderator: Daniella Kranjac, Dynamk Capital

 6:00 PM

Awards and Reception

Mayor Steven Fulop

Speakers

Ben Lehnert

Director of Product Design, Microsoft

Benedikt Lehnert is the Director of Product Design for Outlook at Microsoft, leading a team of 50 designers and researchers across Redmond, New York City, San Francisco and Vancouver. He joined Microsoft in 2015 through the acquisition of Wunderlist, the world’s most loved cross-platform productivity app, where he was the Chief Design Officer. Benedikt joined the Berlin-based startup in 2012 when the company had only 9 employees and has been the driving force behind winning the hearts and minds of millions people across the globe by delivering a beautiful product that is highly functional, yet incredibly simple. During his 4 years a Wunderlist he scaled the product team to 70 people, helped raise funding from world-renowned investors such as Atomico as well as Sequoia Capital, making Wunderlist the first ever investment in a German startup by the legendary Silicon Valley firm. Benedikt grounds his work in the belief that design-led companies are the better businesses, which has led to Wunderlist secure numerous awards and a cult like following. Before joining Wunderlist, Benedikt was the Chief Product Officer at a biotech startup where he led a team of designers and engineers to develop a category-leading suite of hardware and software products to reinvent biobanking. Benedikt is also the author of Typoguide, an international keynote speaker and angel investor in design-driven startups around the world. He lives with his wife, daughter and two dogs in Princeton, NJ.

Kelly Ford

Partner, Edison Partners

A 23-year veteran of emerging and established organizations, Kelly is a cross-discipline operator turned advisor and investor who is passionate about leading and orchestrating growth initiatives that build value and excellence for technology companies pre-revenue to $100M. As Partner at Edison Partners, Kelly advises companies in the areas of go-to-market strategy and operations, organizational alignment and design, and scaling sales and marketing machines. She also serves on the board of directors for Billtrust, Salsa Labs and Axial. Kelly is a Boston native and Michigan State alumn, who now calls Lawrenceville home. She has been recognized as one of the Best 50 Women in Business by NJBIZ and is a frequent speaker at local and national B2B sales and marketing events.

Deborah Zajac

Director, Touchdown Ventures

Deborah is a venture investor with over 20 years working with startups and corporates. As Director at Touchdown Ventures, Deborah has launched and leads venture funds in food and healthcare on behalf of Touchdown’s Fortune 500 corporate partners, having spent a decade at GE Ventures and GE Corporate in corporate venture capital, innovation, and development in frontier technology, healthcare, industrials, consumer, and software. Deborah’s first startup experience was at dot.com SaaS startup Celarix.com. A builder as well as an investor, Deborah launched tech-driven startups and partnerships at Touchdown, GE, and Columbia University Tech Ventures as an Exec-in-Residence. She began her career as management consultant and business unit leader at Andersen Consulting and GE. Deborah is a New Jersey native. Deborah earned her MBA from NYU Stern School of Business and BS and BA from Lehigh University, where she has served as Trustee and founding Advisory Board member of the Baker Institute of Entrepreneurship, Creativity, and Innovation.

Gina Tedesco

Angel Investor, Jumpstart

Gina is an active investor, serial entrepreneur, professor and mentor. Currently managing member of Amala Ventures, a venture firm investing in disruptive technology in the USA and Brazil, Ms. Tedesco's career of over 30 years includes co-founding 3 successful start-up ventures, overseas postings in finance and M&A with a global pharmaceutical company and industry expertise in pharmaceuticals, biotech, and technology. Ms. Tedesco is a member and board member of Jumpstart NJ Angel Network and a member of Golden Seeds. She also serves on the board of two private companies and is an Advisory Board Member of the Rothman Institute of Entrepreneurship. In addition, she is an Adjunct Professor at Fairleigh Dickinson University and is currently teaching various online courses in entrepreneurship. Fluent in English, French and Portuguese, Ms. Tedesco earned a B.S. in Mechanical Engineering from the University of Massachusetts at Amherst (Pi Tau Sigma) and a MBA in International Business with a concentration in Finance from The George Washington University (Magna Cum Laude) as well as an additional post-MBA concentration certificate in Entrepreneurial Studies from Fairleigh Dickinson University.

Kathleen Coviello

Vice President, Technology & Life Sciences Investments

Kathleen Coviello is the Vice President, Technology & Life Sciences Investments (TLS) at the New Jersey Economic Development Authority (EDA). She is responsible for working closely with the emerging technology and life science companies and investors in the state and delivering the various Edison Innovation Fund products to this community. She joined the Authority in August 2005 as a program manager. Under Ms. Coviello’s direction, the EDA has delivered over $1 billion in direct investments, business incentives, tax credits, and venture fund investments through the Edison Innovation Fund. Coviello’s related accomplishments include crafting, for the first time at the EDA, financing instruments in the form of subordinated convertible debt with warrants to support the NJ technology community and the EDA’s conversion in several portfolio companies to be a preferred stock holder. She has also assembled and runs several technology advisory boards comprised of private sector industry specialists, which supports the EDA’s commitment to a public private partnership. She lead EDA’s work with the NJ Pensions Division to, for the first time in NJ, earmark pension investments to NJ based investments in NJ Venture Funds and companies, via the NJ Direct Investment Fund. During her tenure, the TLS division rolled out the EDA’s green technology initiatives; NJ’s first accelerator- TechLaunch was established; Federal SSBCI funds were deployed into several regional venture funds; NJ’s Angel Tax Credit Program was launched and the NJ Founders & Funders progam was born. Coviello also oversees the management of EDA’s Commercialization Center for Innovative Technologies (CCIT), an internationally recognized 46,000 square foot, leading life science incubation facility along with the soon to be opened Biotechnology Development center, a 32,000 square foot post incubation life science facility. Prior to joining the EDA, she spent over seventeen years in the banking industry, with the last eight focused exclusively on the NJ Technology Venture Lending Market. Her venture lending experience includes employment at Silicon Valley Bank, Comerica Bank and Progress’ Techbanc. In 2009, Coviello was the recipient of the John H. Martinson, Technology Leadership Award by the New Jersey Technology Council, an award recognizing her leadership in the NJ Technology community over the last ten years. She was named “Financier of the Year” by the New Jersey Technology Council in June of 2003 and had been a finalist in June 2001. Coviello actively participates in numerous technology forums throughout the state as a speaker, judge and panelist. Coviello sits on the advisory and/or valuation boards of the Edison Venture Fund, , the NJTC Venture Fund/Tech Council Ventures, and New Spring Health Ventures. She is also sits on the boards of the NJ Technology Council, and the NJ R&D council. Ms. Coviello received her undergraduate degree in Business Administration from Albright College in Reading, PA, and she received her Masters in Business Administration with a specialization in Finance from LaSalle University in Philadelphia, PA. Ms. Coviello resides in Hillsborough, NJ with her husband and three children.

Daniella Kranjac

Co-Founder & Managing Director, Dynamk Capital LLC

Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for over 16 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007. At GE Healthcare, Daniella held a variety of strategic and business development roles of increasing responsibility. One of her most notable achievements is the success in an entrepreneurial group within the broader GE Healthcare, where a focus on integrating the acquired Xcellerex business enabled global commercialization of a several hundred million dollar enterprise solutions business. Her extensive business development, negotiations and deal-making experience with multinational biopharma and governments in developed and emerging markets provides Dynamk with a broad network of colleagues, customers, innovators and industry leaders. Ms. Kranjac’s unique perspective on the global market is owed to varied experiences in pharma, biologics and biosimilars, vaccines and cell therapies as these markets have evolved in the United States, Europe, Latin America, Brazil, Turkey, Russia, China and the Middle East. She has consistently worked to foster strong client relationships and recognition among industry thought leaders, and has a deep expertise in product management and positioning, sales, business development and internal commercial operations. As the founder of Dynamk Consulting LLC, Ms. Kranjac provides market insights, competitive analysis, strategy and business development, commercial operations and tactical marketing to life sciences and biopharma business to business companies. She provides advisory services to high growth entrepreneurial executive and management teams in the space and the opportunities resulting from these consulting efforts have given rise to the establishment of Dynamk Capital LLC.

Array
(
    [0] => WP_Post Object
        (
            [ID] => 31
            [post_author] => 1
            [post_date] => 2018-01-31 14:37:44
            [post_date_gmt] => 2018-01-31 14:37:44
            [post_content] => 
            [post_title] => Ben Lehnert
            [post_excerpt] => Benedikt Lehnert is the Director of Product Design for Outlook at Microsoft, leading a team of 50 designers and researchers across Redmond, New York City, San Francisco and Vancouver. He joined Microsoft in 2015 through the acquisition of Wunderlist, the world’s most loved cross-platform productivity app, where he was the Chief Design Officer. Benedikt joined the Berlin-based startup in 2012 when the company had only 9 employees and has been the driving force behind winning the hearts and minds of millions people across the globe by delivering a beautiful product that is highly functional, yet incredibly simple. During his 4 years a Wunderlist he scaled the product team to 70 people, helped raise funding from world-renowned investors such as Atomico as well as Sequoia Capital, making Wunderlist the first ever investment in a German startup by the legendary Silicon Valley firm. Benedikt grounds his work in the belief that design-led companies are the better businesses, which has led to Wunderlist secure numerous awards and a cult like following. 
Before joining Wunderlist, Benedikt was the Chief Product Officer at a biotech startup where he led a team of designers and engineers to develop a category-leading suite of hardware and software products to reinvent biobanking. Benedikt is also the author of Typoguide, an international keynote speaker and angel investor in design-driven startups around the world. He lives with his wife, daughter and two dogs in Princeton, NJ.

            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => benedikt-lehnert
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-02-12 15:07:26
            [post_modified_gmt] => 2018-02-12 15:07:26
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=31
            [menu_order] => 0
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [1] => WP_Post Object
        (
            [ID] => 35
            [post_author] => 1
            [post_date] => 2018-01-31 16:15:18
            [post_date_gmt] => 2018-01-31 16:15:18
            [post_content] => 
            [post_title] => Kelly Ford
            [post_excerpt] => A 23-year veteran of emerging and established organizations, Kelly is a cross-discipline operator turned advisor and investor who is passionate about leading and orchestrating growth initiatives that build value and excellence for technology companies pre-revenue to $100M. As Partner at Edison Partners, Kelly advises companies in the areas of go-to-market strategy and operations, organizational alignment and design, and scaling sales and marketing machines. She also serves on the board of directors for Billtrust, Salsa Labs and Axial.

 
Kelly is a Boston native and Michigan State alumn, who now calls Lawrenceville home. She has been recognized as one of the Best 50 Women in Business by NJBIZ and is a frequent speaker at local and national B2B sales and marketing events.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => kelly-ford
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-02-12 15:07:46
            [post_modified_gmt] => 2018-02-12 15:07:46
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=35
            [menu_order] => 2
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [2] => WP_Post Object
        (
            [ID] => 61
            [post_author] => 1
            [post_date] => 2018-02-23 14:24:14
            [post_date_gmt] => 2018-02-23 14:24:14
            [post_content] => 
            [post_title] => Deborah Zajac
            [post_excerpt] => Deborah is a venture investor with over 20 years working with startups and corporates. As Director at Touchdown Ventures, Deborah has launched and leads venture funds in food and healthcare on behalf of Touchdown’s Fortune 500 corporate partners, having spent a decade at GE Ventures and GE Corporate in corporate venture capital, innovation, and development in frontier technology, healthcare, industrials, consumer, and software.

Deborah’s first startup experience was at dot.com SaaS startup Celarix.com. A builder as well as an investor, Deborah launched tech-driven startups and partnerships at Touchdown, GE, and Columbia University Tech Ventures as an Exec-in-Residence. She began her career as management consultant and business unit leader at Andersen Consulting and GE.

Deborah is a New Jersey native. Deborah earned her MBA from NYU Stern School of Business and BS and BA from Lehigh University, where she has served as Trustee and founding Advisory Board member of the Baker Institute of Entrepreneurship, Creativity, and Innovation.  


            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => deborah-zajac
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-02-23 15:26:34
            [post_modified_gmt] => 2018-02-23 15:26:34
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=61
            [menu_order] => 3
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [3] => WP_Post Object
        (
            [ID] => 33
            [post_author] => 1
            [post_date] => 2018-01-31 16:11:50
            [post_date_gmt] => 2018-01-31 16:11:50
            [post_content] => 
            [post_title] => Gina Tedesco
            [post_excerpt] => Gina is an active investor, serial entrepreneur, professor and mentor. Currently managing member of Amala Ventures, a venture firm investing in disruptive technology in the
USA and Brazil, Ms. Tedesco's career of over 30 years includes co-founding 3 successful start-up ventures, overseas postings in finance and M&A with a global pharmaceutical company and industry expertise in pharmaceuticals, biotech, and technology.
Ms. Tedesco is a member and board member of Jumpstart NJ Angel Network and a member of Golden Seeds. She also serves on the board of two private companies and is an Advisory Board Member of the Rothman Institute of Entrepreneurship. In addition, she is an Adjunct Professor at Fairleigh Dickinson University and is currently teaching various online courses in entrepreneurship.
Fluent in English, French and Portuguese, Ms. Tedesco earned a B.S. in Mechanical Engineering from the University of Massachusetts at Amherst (Pi Tau Sigma) and a MBA in International Business with a concentration in Finance from The George Washington University (Magna Cum Laude) as well as an additional post-MBA concentration certificate in Entrepreneurial Studies from Fairleigh Dickinson University.
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => gina-tedesco
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-02-12 15:08:10
            [post_modified_gmt] => 2018-02-12 15:08:10
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=33
            [menu_order] => 4
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [4] => WP_Post Object
        (
            [ID] => 29
            [post_author] => 1
            [post_date] => 2018-01-30 19:09:11
            [post_date_gmt] => 2018-01-30 19:09:11
            [post_content] => 
            [post_title] => Kathleen Coviello
            [post_excerpt] => Kathleen Coviello is the Vice President, Technology & Life Sciences Investments (TLS) at the New Jersey Economic Development Authority (EDA). She is responsible for working closely with the emerging technology and life science companies and investors in the state and delivering the various Edison Innovation Fund products to this community.  She joined the Authority in August 2005 as a program manager.

Under Ms. Coviello’s direction, the EDA has delivered over $1 billion in direct investments, business incentives, tax credits, and venture fund investments through the Edison Innovation Fund.  Coviello’s related accomplishments include crafting, for the first time at the EDA, financing instruments in the form of subordinated convertible debt with warrants to support the NJ technology community and the EDA’s conversion in several portfolio companies to be a preferred stock holder. She has also assembled and runs several technology advisory boards comprised of private sector industry specialists, which supports the EDA’s commitment to a public private partnership.  She lead EDA’s work with the NJ Pensions Division to, for the first time in NJ, earmark pension investments to NJ based investments in NJ Venture Funds and companies, via the NJ Direct Investment Fund.  During her tenure, the TLS division rolled out the EDA’s green technology initiatives; NJ’s first accelerator- TechLaunch was established; Federal SSBCI funds were deployed into several regional venture funds; NJ’s Angel Tax Credit Program was launched and the NJ Founders & Funders progam was born.  Coviello also oversees the management of EDA’s Commercialization Center for Innovative Technologies (CCIT), an internationally recognized 46,000 square foot, leading life science incubation facility along with the soon to be opened Biotechnology Development center, a 32,000 square foot post incubation life science facility. 
 
Prior to joining the EDA, she spent over seventeen years in the banking industry, with the last eight focused exclusively on the NJ Technology Venture Lending Market. Her venture lending experience includes employment at Silicon Valley Bank, Comerica Bank and Progress’ Techbanc.  

In 2009, Coviello was the recipient of the John H. Martinson, Technology Leadership Award by the New Jersey Technology Council, an award recognizing her leadership in the NJ Technology community over the last ten years.  She was named “Financier of the Year” by the New Jersey Technology Council in June of 2003 and had been a finalist in June 2001.  Coviello actively participates in numerous technology forums throughout the state as a speaker, judge and panelist.
 
Coviello sits on the advisory and/or valuation boards of the Edison Venture Fund, , the NJTC Venture Fund/Tech Council Ventures, and New Spring Health Ventures.  She is also sits on the boards of the NJ Technology Council, and  the NJ R&D council.

Ms. Coviello received her undergraduate degree in Business Administration from Albright College in Reading, PA, and she received her Masters in Business Administration with a specialization in Finance from LaSalle University in Philadelphia, PA.

Ms. Coviello resides in Hillsborough, NJ with her husband and three children. 



            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => kathleen-coviello
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-04-04 20:10:13
            [post_modified_gmt] => 2018-04-04 20:10:13
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=29
            [menu_order] => 5
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

    [5] => WP_Post Object
        (
            [ID] => 156
            [post_author] => 1
            [post_date] => 2018-04-05 13:36:23
            [post_date_gmt] => 2018-04-05 13:36:23
            [post_content] => 
            [post_title] => Daniella Kranjac
            [post_excerpt] => Daniella Kranjac has been building life sciences businesses, developing and commercializing life sciences products for over 16 years. Having co-founded Wave Biotech LLC from her dormitory room, she and a partner drove the start-up, growth and commercialization of a highly disruptive technology. As Vice President of the organization, Daniella established a high growth company with significant brand recognition, and led the group to a successful exit and acquisition by GE Healthcare in 2007.  

At GE Healthcare, Daniella held a variety of strategic and business development roles of increasing responsibility.  One of her most notable achievements is the success in an entrepreneurial group within the broader GE Healthcare, where a focus on integrating the acquired Xcellerex business enabled global commercialization of a several hundred million dollar enterprise solutions business. Her extensive business development, negotiations and deal-making experience with multinational biopharma and governments in developed and emerging markets provides Dynamk with a broad network of colleagues, customers, innovators and industry leaders.

Ms. Kranjac’s unique perspective on the global market is owed to varied experiences in pharma, biologics and biosimilars, vaccines and cell therapies as these markets have evolved in the United States, Europe, Latin America, Brazil, Turkey, Russia, China and the Middle East. She has consistently worked to foster strong client relationships and recognition among industry thought leaders, and has a deep expertise in product management and positioning, sales, business development and internal commercial operations.  

As the founder of Dynamk Consulting LLC, Ms. Kranjac provides market insights, competitive analysis, strategy and business development, commercial operations and tactical marketing to life sciences and biopharma business to business companies.  She provides advisory services to high growth entrepreneurial executive and management teams in the space and the opportunities resulting from these consulting efforts have given rise to the establishment of Dynamk Capital LLC. 
            [post_status] => publish
            [comment_status] => closed
            [ping_status] => closed
            [post_password] => 
            [post_name] => daniella-kranjac
            [to_ping] => 
            [pinged] => 
            [post_modified] => 2018-04-05 13:36:23
            [post_modified_gmt] => 2018-04-05 13:36:23
            [post_content_filtered] => 
            [post_parent] => 0
            [guid] => https://events.njtc.org/vc18/?post_type=events_speakers&p=156
            [menu_order] => 6
            [post_type] => events_speakers
            [post_mime_type] => 
            [comment_count] => 0
            [filter] => raw
        )

)

Sponsors

Signature Sponsor

Conference Sponsor

Supporting Orgs

Registration

Members: $125; Future Members: $245
Non-Sponsor Prof. Advisor Firms: Members: $245; Future Members: $395
Students: $40

REGISTRATION IS CLOSED - WALK-INS WELCOME. If you have a discount code, it will be honored at registration desk.